Clinical Trials Arena2d
Palatin’s UC therapy prompts clinical remission in a third of patients
Results from the company’s Phase II trial also saw PL8177 elicit a clinical response in 77% of ulcerative colitis patients.
Clinical Trials Arena2d
Medidata introduces programme to expedite therapy delivery to trial subjects
Medidata has launched the Medidata Site Insights Program, aimed at expediting the delivery of life-changing therapy to trial ...
Clinical Trials Arena2d
MSD’s subcutaneous Keytruda non-inferior to IV version of blockbuster drug
Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...
Clinical Trials Arena2d
WCG launches SaaS solution to optimise trial site selection
Clinical trial solutions provider WCG has launched the new SaaS technology, ClinSphere Total Feasibility, to enhance site ...
Clinical Trials Arena2d
MedUni Vienna physicians develop tool to enhance trial access
MedUni Vienna physicians Daniel Aletaha and Josef Smolen have developed the Preferrix digital tool to enhance clinical trial ...
clinicaltrialsarena3d
Sigrid’s Carb Fence tech targets patients being left behind by GLP1s
The company claims that Carb Fence can transform traditional fast food into what it calls ‘slow food.’ Credit: Shutterstock / Rimma Bondarenko. While GLP-1 receptor agonists (GLP-1RAs) are taking up ...
Clinical Trials Arena3d
Study explores the relationship between green spaces and childhood obesity
Childhood obesity is a formidable public health challenge in the US, posing a risk of various downstream health issues for ...